NEWARK, Del, July 28, 2022 (GLOBE NEWSWIRE) -- As per a latest industry analysis by Future Market Insights, the global interferons market was valued at around US$ 9.1 Bn in 2021 and is anticipated to grow at US$ 13.8 Bn in 2032, exhibit a CAGR of 3.9% over the forecast period (2022-2032).
A group of proteins produced by white blood cells, fibroblasts, and T-cells in response to viral infections, bacteria, tumor cells, and other pathogens are known as interferons. These glycoproteins, also known as cytokines, are frequently referred to as the first line of defense against pathogens.
Interferons have proved to be a cutting-edge and successful treatment option for illnesses such as cancer, hepatitis, and multiple sclerosis. In November 2021, for instance, the FDA approved BESREMi for the treatment of adults living with polycythemia vera, which is a recent advancement in the interferons industry.
Polycythemia vera is a group of rare, chronic, and life-threatening blood cancers caused by a mutation in bone marrow stem cells, which further leads to an abundance of blood cells. When this happens, a person is at high risk of significant health problems such as blood clots, strokes, and heart attacks.
Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15158
One of the other factors driving the global interferons market is rising focus of key players on the development of innovative interferon-beta medications. Key players are also focusing on expanding their presence with the help of promotions, improved distribution networks, and enhanced customer services related to their products for the betterment of the brand and products.
For instance, in March 2020, Bayer and Curadev signed a research collaboration and license agreement to develop a novel stimulator of interferon genes (STING) antagonists across indications. It is known to help activate the innate immune system in auto-inflammatory diseases. Such breakthroughs in the global market are projected to bode well for the interferons industry in the upcoming decade.
Key Takeaways: Interferons Market
- By product, interferon beta is the leading segment with a market share of around 47.2% in 2021.
- In terms of indication, the multiple sclerosis segment dominates the interferons market and held a share of around 35.0% in 2021.
- Based on end user, hospital pharmacies are expected to lead the interferons market and it generated a share of nearly 43.5% in 2021.
- North America is considered to be the leading region in the interferons market with a share of about 37.2% in 2021.
“Growing number of therapeutic interferon approvals and their surging commercial applications in several disease indications are expected to propel the global interferons market,” says an analyst of Future Market Insights.
Ask Our Analyst More about Report @ https://www.futuremarketinsights.com/ask-question/rep-gb-15158
Competitive Landscape: Interferons Market
Leading manufacturers such as Pfizer, Merck & Co., Zydus Cadila, and Novartis AG are focusing on collaborations and acquisitions to enhance their presence in the market and compete with their rivals during the forecast period. Below are some of the latest industry developments by key market participants:
- In March 2022, Pfizer completed the acquisition of Arena Pharmaceuticals to expand its inflammation and immunology therapeutics segment.
- In January 2022, Pfizer and Beam Therapeutics announced an exclusive collaboration to explore innovative In Vivo base editing projects for three targets in rare genetic illnesses of the liver, muscle, and central nervous system.
- In January 2022, Merck & Co. completed the acquisition of Exelead and aims to invest more than € 500 million in technical scale-up. Merck's Life Science business segment will be able to provide comprehensive end-to-end contract development and manufacturing organization (CDMO) services across the mRNA value chain as a result of the acquisition.
More Valuable Insights on Interferons Market:
Future Market Insights brings a comprehensive research report on projected revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2032.
The global interferons market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the interferons market segments based on product (interferon gamma, interferon beta, and interferon alpha), indication (multiple sclerosis, polycythemia vera, hepatitis C, melanoma, chronic granulomatous disease (CGD), and other indications), and end user (hospital pharmacies, retail pharmacies, specialty clinics, and online pharmacies) across seven major regions.
Request For Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-15158
Interferons Market Outlook by Category
By Product:
- Interferon Gamma
- Interferon Beta
- Interferon Alpha
By Indication:
- Multiple Sclerosis
- Polycythemia Vera
- Hepatitis C
- Melanoma
- Chronic Granulomatous Disease (CGD)
- Other Indications
By End User:
- Hospital Pharmacies
- Retail Pharmacies
- Specialty Clinics
- Online Pharmacies
Buy Now@ https://www.futuremarketinsights.com/checkout/15158
About Healthcare Division at Future Market Insights
Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption/Usage Analysis
4.2. Pipeline Assessment
4.3. Regulatory Landscape
4.4. Reimbursement Outlook
4.5. Key Marketing & Promotional Strategies Adopted By Companies
Request a Complete TOC of this Report with figures@ https://www.futuremarketinsights.com/toc/rep-gb-15158
Have a Look at Related Research Reports of Healthcare Market Insights
Sialendoscopes Market Size: Sialendoscopes market is generating total revenue of US$ 169.2 Million in 2022 is predicted to reach US$ 307.9 Million by the end of year 2032.
Veterinary Injectable Devices Market Outlook: Veterinary injectable devices market is poised to witness a CAGR of 2.3% during the years 2022 to 2032.
Scoliosis Management Market Trends: Scoliosis management market is likely to record a CAGR of 3.9% during the forecast period, up from US$ 2,942.8 Mn in 2022 to reach a valuation of US$ 4,489.0 Mn by 2032.
Intracranial Aneurysm Market Growth: Intracranial aneurysm market is set to flourish in the global market at a promising CAGR of 8.8% between 2022 and 2032.
Revision Knee Replacement Market Analysis: Revision knee replacement market is likely to rise to US$ 1.3 Billion in 2022. The revision knee replacement market is estimated to reach US$ 2 Billion with a CAGR of 4.1% by 2032.
Airway Disease Treatment Market Forecast: Airway disease treatment market is projected to amass a revenue of around US$ 3,495.3 million by 2032, up from US$ 1,996.1 million in 2022 moving forward with a CAGR of 5.2% during the forecast period.
Dermatology Cryosurgery Units Market Demand: Dermatology cryosurgery units are expected to reach US$ 305.7 Million by 2032, up from US$ 145.8 Million in 2022. From 2022-2032, the expected CAGR is 7%, while it was valued at 6.4% from 2016-21.
Assisted Walking Devices Market Value: Assisted walking devices market is augmented to hold the market revenue of USD 3.62 Billion in 2022 while it thrives on the CAGR of 6.4% between 2022 and 2032. The market is anticipated to reach USD 6.33 Billion by 2032.
MRI Compatible Patient Monitoring Systems Market Overview: MRI compatible patient monitoring systems market is projected to be valued at US$ 5,958.6 million by 2032, up from US$ 3,851.4 million in 2022, advancing at a CAGR of 4% from 2022 to 2032.
Tibial Neuromodulation Devices Market Share: Tibial neuromodulation devices are projected to rise at a CAGR of 8.1% during the forecast period 2022-2032.
About Us
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/interferons-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse Other Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
